Member since: Wed Feb 10, 2010, 12:12 PM
Number of posts: 3,738
Number of posts: 3,738
- 2015 (26)
- 2014 (205)
- 2013 (273)
- 2012 (105)
- Older Archives
Hershey's Milk Chocolate and Kisses to go non-GM
By Oliver Nieburg+, 23-Feb-2015
Hershey intends to remove genetically-modified ingredients from Hershey’s Milk Chocolate and Kisses by the end of the year.
COPYRIGHT PROTECTED TEXT
via Robyn O'Brien @foodawakenings · Feb 23
Posted by proverbialwisdom | Wed Feb 25, 2015, 04:25 AM (0 replies)
Great overview. Check it out, or... (go reflexively with the "skeptics" and pretend attacking the messenger, JB Handley, is the same as addressing the specific content of his testimony).
TESTIMONY: Senate Committee on Health Care, State of Oregon, SB 442
February 18, 2015, 3pm
Respectfully Submitted: Jonathan B. Handley, Portland, OR
I was born in 1969. My father worked for the U.S. Government and I spent my childhood living in foreign countries, including the third world. Specifically, I was born in Singapore, then lived in Laos, Mexico, Korea, Japan, India, and the Philippines.
Handley? Dual B.A. degrees in East Asian Studies and Economics, with honors, from Stanford University; private equity fund co-founder.
No, of course, I don't agree with everything Handley has ever publicly stated that I've read. Occasional OPINIONS are cringeworthy, IMO. However, when strictly documenting the FACTS, as presented in the testimony provided (above), Handley is HIGHLY ORGANIZED AND EXCEEDINGLY FORMIDABLE. Supporting documents at link.
Posted by proverbialwisdom | Sat Feb 21, 2015, 03:18 AM (4 replies)
See "Pregnancy Registries"
TRANSCRIPT OF VIDEO BELOW:
Senior CDC Scientist and Whistleblower Dr. William W. Thompson:
"You know in the United States the only vaccine it's still in is for pregnant women.
Warning: Gratuitous image (fake 'fire' on pregnant abdomen) near end of 1:02 minute video. To avoid, listen to audio only.
CDC Whistleblower Dr. Thompson on Thimerosal and Pregnant Women
Published on Aug 27, 2014
Posted by proverbialwisdom | Fri Feb 20, 2015, 03:59 AM (0 replies)
Meeting Material SB 442 Jonathan Handley Testimony Resident
Posted by proverbialwisdom | Wed Feb 18, 2015, 06:35 PM (0 replies)
Balanced mainstream overview, IMO.
Parents of Vaccine-Injured Children Speak Out
February 17, 2015
Posted by proverbialwisdom | Wed Feb 18, 2015, 06:09 PM (0 replies)
NORTH AMERICAN JOURNAL OF MEDICINE & SCIENCE
July 2013 (Volume 6, Issue 3)
Preface to the special issue of autism
Autism spectrum disorder (ASD), the fastest-growing complex neurodevelopment disorder, continues to rise in its prevalence, now affecting up to 1 in 50 children in the USA, and averaging 1% globally, according to the latest CDC report. More children will be diagnosed with ASD this year than with AIDS, diabetes & cancer combined in the USA. ASD costs the nation $137 billion a year and this debt is expected to increase in the next decade. Hence, ASD has become a huge healthcare burden and global threat, categorized by the CDC as a national public health crisis.
ASD is characterized by social-communication impairment, and restricted, repetitive, and stereotyped patterns of behavior, which cause significant disability for those affected. With its etiology still largely unknown, and its pathophysiology poorly understood, ASD currently has no universally accepted therapy. ASD is affecting more and more families; unmet services and limited resources need to be addressed urgently. Researchers, clinicians, healthcare providers, social agencies and government need to coordinate efforts to develop more effective treatments and a satisfactory continuum of care, across the lifespan. Ultimately, a cure needs to be sought for the various subtypes of ASD that exist.
The current issue of North American Journal of Medicine and Science (NAJMS) represents a continuation of our previous two special issues on autism (NAJMS Vol. 5 Issue 3 and Vol. 4 Issue 3) published in July 2012 and July 2011, respectively. In this issue, we are honored to have another panel of expert researchers and clinicians on the frontlines of ASD research and treatment to present their newest research findings and views from different perspectives.
This issue of NAJMS consists of five original research articles, two comprehensive reviews, one case report and two commentary articles, covering topics in genetics, pathogenesis, metabolic disorder biomarkers of ASD, and a clinical study, that bring into focus our newest understanding and treatment strategies.
The data presented in Dr. Mumper’s review of the medical literature, suggests that ASD may be impacted by environmental toxicants, duration of breastfeeding, gut flora composition, nutritional status, acetaminophen use, vaccine practices and use of antibiotics and/or frequency of infections. In her current general pediatric practice (Advocates for Children), she has noted a modest trend toward a lower prevalence of ASD than in her previous pediatric practice or recent prevalence estimates from the CDC.
The final commentary was written by Dr. Herbert, who presents her paper entitled “Everyday Epigenetics from Molecular Intervention to Public Health and Lifestyle Medicine.” She asserts that it may well take a grass roots epigenetic/lifestyle medicine revolution to avert the worsening health trends we are facing in the setting of a progressively more toxic and endangered planet. She posits that everyday epigenetics can inform science of what is possible so that society can respond on an appropriate scale to the magnitude of the crisis we are facing.
We would like to thank all the contributors to this special issue of autism for offering their great expertise in this area, as well as all the peer reviewers for their valuable critiques, comments and precious time. We would like to thank our editorial colleagues for their dedication and collaborative team work with shared vision and spirit. With all our efforts together, we have made this important issue on advances in autism possible.
Finally, we would like to thank our family members for their continuous encouragement and support.
Xuejun Kong, MD
Department of Medicine
Beth Israel Deaconess Medical Center
Harvard Medical School
Christopher J. McDougle, MD
Guest Editor, NAJMS
Lurie Center for Autism Massachusetts General Hospital
Harvard Medical School
Inclusion criteria were: 1) all general pediatric patients born in 2005 or later; 2) presented for well child care prior to 2 months of birth and 3) followed until at least the age of 2 years and 2 months. Totally 294 patients qualified for the inclusion criteria and have been selected in the current research.
All the patients have been treated and examined utilizing the same well child procedures. The electronic records for all infants cared for in our general pediatrics practice since July 1, 2005 who visited our office from prior to 2 months of age (usually in the first 3-5 days after birth) to at least the age of 2 years and 2 months have been reviewed and examined, since the age range would provide ample opportunity to observe symptoms of autism. Their developmental milestones in the domains of gross and fine motor, speech and language, and social behaviors at each of 11 well child visits in the first 2 years of life have been recorded. The medical record is marked for any child who does not meet milestones. No new cases of autism in our general pediatric practice since it was established in 2000 have been recorded; the current research reports on the cohort born in 2005 or after. CDC prevalence disease data and other published data have been utilized in analysis of this research.
In the current research, there are no new cases of autism out of the 294 cases recognized and recorded, resulting in 0% prevalence of ASD. Based on the CDC background risk of autism of 1 in 50 for the cohort born around 2005 we would expect to have about 6 new cases of autism in our practice. We calculated our statistics using a Chi-squared test with 1 degree of freedom. Using the CDC autism rate of 1 in 50 reported in 2013 (but based on surveys of eight year old children), the expected rate for our 294 patients starting in 2005 would be 5.88 children with autism. Zero new cases of autism would occur by chance 1.4% of the time (p-value 0.014, significant at 0.05).
Posted by proverbialwisdom | Tue Feb 17, 2015, 12:08 PM (1 replies)
They might disagree with Dr. Anne Schuchat, a rear admiral for the U.S. Public Health Service Commissioned Corps and the director for the National Center for Immunization and Respiratory Diseases at the CDC. Is that allowed?
These Harvard-affiliated physicians, researchers and scientists are even Senator Warren's constituents, as residents of Massachusetts.
Posted by proverbialwisdom | Sun Feb 15, 2015, 03:05 PM (1 replies)
Please examine the evolution of the vaccine schedule. Please extrapolate future trends. Then carefully define your terms.
History of Vaccine Schedule
Reviewed by: Paul A. Offit, MD
Date: April 2013
A look at the late-stage vaccine pipeline
November 11, 2010 | By Maureen Martino
In 2009, the world market for preventive vaccines totaled $22.1 billion, up from $19.0 billion in 2008, and is expected to grow at a compound annual rate of 9.7 percent to $35 billion in 2014. That's according to Kalorama Information, which has broken out a list of notable vaccines in late-stage development. Merck, GlaxoSmithKline, Sanofi Pasteur, Pfizer and Novartis combined control 83.9 percent of the world market, with GSK being the biggest vaccine seller.
As of mid-2010, Kalorama estimates there are more than 200 pediatric vaccines and many more adult preventative vaccines in development, although most are at the earliest stages of the testing process.
Posted by proverbialwisdom | Fri Feb 13, 2015, 01:55 PM (1 replies)
CASE: Bruesewitz v. Wyeth
RECAP: The Supreme Court majority concluded that manufacturers could NOT be sued even for faulty product design because their products are categorized as "unavoidably unsafe" (rarely... for some).
Justices Sotomayor and Ginsberg DISSENTED (28 pages).
NYT (link below): In a final footnote, Justice Sotomayor wrote that a concern about an asserted link “between certain vaccines and autism spectrum disorders” appeared to “underlie the majority and concurring opinions in this case.” <> In any event, she said, “Congress intended to leave the courthouse doors open for children who have suffered severe injuries from defectively designed vaccines.”
Tea Party, baloney. That's not actually how people line up. Developing...
Posted by proverbialwisdom | Fri Feb 13, 2015, 01:44 PM (0 replies)
Since the first National Vaccine Injury Compensation (VICP) claims were filed in 1989, 3,941 compensation awards have been made. More than $2.8 billion in compensation awards has been paid to petitioners and more than $121.6 million has been paid to cover attorneys' fees and other legal costs.
Oversimplification is SPIN, regretably.
Posted by proverbialwisdom | Thu Feb 12, 2015, 01:46 PM (0 replies)